HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 48.75
Day range
kr 48.70 - kr 50.30
Year range
kr 31.20 - kr 84.30
Market cap
635.28M SEK
Avg Volume
13.16K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.84M | -67.96% |
Net income | -10.05M | 69.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 165.26M | -26.94% |
Total assets | 178.23M | -25.52% |
Total liabilities | 53.87M | 52.71% |
Total equity | 124.36M | — |
Shares outstanding | 13.47M | — |
Price to book | 5.28 | — |
Return on assets | -14.59% | — |
Return on capital | -20.94% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.05M | 69.21% |
Cash from operations | -8.36M | 80.10% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -11.06M | 76.12% |
Free cash flow | -7.78M | 77.64% |
About
Founded
2011
Website
Employees
8
